Repurposing a Drug Targeting Inflammatory Bowel Disease for Lowering Hypertension

BACKGROUND: The gut and gut microbiota, which were previously neglected in blood pressure regulation, are becoming increasingly recognized as factors contributing to hypertension. Diseases affecting the gut such as inflammatory bowel disease (IBD) present with aberrant energy metabolism of colonic e...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Xue, Mell, Blair, Manandhar, Ishan, Aryal, Sachin, Tummala, Ramakumar, Kyoung, Jun, Yang, Tao, Joe, Bina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798790/
https://www.ncbi.nlm.nih.gov/pubmed/36533597
http://dx.doi.org/10.1161/JAHA.122.027893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798790/
https://www.ncbi.nlm.nih.gov/pubmed/36533597
http://dx.doi.org/10.1161/JAHA.122.027893

Ejemplares similares